Historical record - last NADAC effective date: 12/23/2022
Product Information
ENVARSUS XR 1 MG TABLET is a brand product labeled by Veloxis Pharmaceuticals, Inc, priced at $6.1904 per EA under NDC 68992301003. Its NADAC has been published 78 times since Oct 20, 2021.
FDA first approved this application on Jul 10, 2015.
The High Outlier badge above means this manufacturer's average price in the Tacrolimus market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 mg/1
Manufacturer
Veloxis Pharmaceuticals, IncNDC
68992301003
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
12/23/2022
Active Ingredients
TACROLIMUSApproval Type
New Drug (NDA)
FDA Application
NDA206406FDA Approved
7/10/2015
On Market Since
9/1/2015
Pharmacological Classes
Price Statistics
The NADAC for ENVARSUS XR 1 MG TABLET has been published 78 times since Oct 20, 2021, and over the history we have for it it has risen 10.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.1904 per EA |
|---|---|
| All-time high | $6.1904 (Apr 12, 2023) |
| All-time low | $5.5833 (Oct 20, 2021) |
| Median price | $5.9810 |
| Average price | $5.9055 |
| Largest weekly change | +3.5% (Dec 28, 2022) |
| Weeks tracked | 78 |
| Tracking since | Oct 20, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+10.9%
Last surveyed Apr 12, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ENVARSUS XR 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ENVARSUS XR 1 MG TABLET, manufactured by Veloxis Pharmaceuticals, Inc, is $6.1904 per EA (NDC 68992301003), effective Apr 12, 2023.
How has the price of ENVARSUS XR 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for ENVARSUS XR 1 MG TABLET has risen 10.9%. It has been tracked across 78 weekly CMS publications since Oct 20, 2021.
What are the highest and lowest recorded NADAC prices for ENVARSUS XR 1 MG TABLET?
Since Oct 20, 2021, the NADAC for ENVARSUS XR 1 MG TABLET has ranged from a low of $5.5833 (Oct 20, 2021) to a high of $6.1904 (Apr 12, 2023), with a median of $5.9810 per EA.
Are there cheaper alternatives to ENVARSUS XR 1 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ENVARSUS XR 1 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ENVARSUS XR 1 MG TABLET?
ENVARSUS XR 1 MG TABLET (NDC 68992301003) is labeled by Veloxis Pharmaceuticals, Inc, and CMS classifies it as a brand product.